VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
VolitionRx Appoints Louise Day as Chief Marketing and Communications Officer 2016-04-14 19:00
VolitionRx to Participate in 2016 Morgan Stanley Healthcare Insight Series 2016-04-11 19:00
VolitionRx to Present at AACR Annual Meeting and Announce First Results from Prostate Cancer Study 2016-04-08 19:00
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer 2016-04-07 19:08
VolitionRx Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full 2016-03-23 23:30
VolitionRx Announces Pricing of Public Offering of Common Stock 2016-03-18 21:29
VolitionRx Announces Proposed Public Offering of Common Stock 2016-03-18 04:01
VolitionRx Announces Full Year 2015 Financial Results and Business Update 2016-03-11 20:35
VolitionRx Schedules Full-Year 2015 Earnings Conference Call and Business Update for Friday, March 11, 2016 at 8:30am ET 2016-03-09 21:30
Preliminary Data Demonstrates 86% Accuracy in Detecting Idiopathic Pulmonary Fibrosis, a Fatal Lung Disease 2016-03-09 20:00
VolitionRx Demonstrates 75% Accuracy in Detecting Highest-Risk Pre-Cancerous Colorectal Adenomas with NuQ(R) Blood Test 2016-02-17 20:00
VolitionRx and Cancer Survivor Sean Swarner Celebrate World Cancer Day with Message of Hope for Cancer Survival Through Early Detection 2016-02-04 20:00
VolitionRx Initiates Prostate Cancer Study in Collaboration with the Surrey Cancer Research Institute, University of Surrey, UK 2016-02-02 20:00
VolitionRx Receives International ISO Certification for Quality Management System of its NuQ(R) Blood Tests 2016-01-28 20:00
VolitionRx Releases Annual Shareholder Update Letter 2016-01-13 20:00
VolitionRx Granted Its Third U.S. Patent 2016-01-04 20:00
VolitionRx Demonstrates More Than 90% Accuracy for Colorectal Cancer NuQ(R) Blood Test in Completed Prospective Study 2015-12-08 20:00
VolitionRx to Present at LD Micro Conference on December 3 in Los Angeles 2015-11-30 20:00
VolitionRx Demonstrates NuQ(R) Blood Test Detects Lung Cancers with more than 90% Accuracy 2015-11-19 20:00
VolitionRx Granted Its Second U.S. Patent 2015-11-17 22:00
1 7 8 9 10 11